Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th November 1, 2024
Nexalin Technology Announces Landmark Study on Alzheimer’s Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer’s Disease October 28, 2024
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA October 22, 2024
